Nicotinamide for the treatment of heart failure with preserved ejection fractionMahmoud Abdellatif, Simon Sedej, Viktoria Trummer-Herbst et al.|Science Translational Medicine|2021Cited by 207
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical UseZoltán Papp, Bojan Vrtovec, Piergiuseppe Agostoni et al.|Journal of Cardiovascular Pharmacology|2020Cited by 111
Fine-Tuning Cardiac Insulin-Like Growth Factor 1 Receptor Signaling to Promote Health and LongevityMahmoud Abdellatif, Simon Sedej, Viktoria Trummer-Herbst et al.|Circulation|2022Cited by 106
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical UseZoltán Papp, Bojan Vrtovec, Piergiuseppe Agostoni et al.|Cardiac failure review|2020Cited by 67
Baseline Characteristics of Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF TrialScott D. Solomon, Dirk von Lewinski, Imran Zainal Abidin et al.|European Journal of Heart Failure|2024Cited by 62